Thought leaders in diabetes provide closing remarks about the importance of continuous awareness of glycemic control in patients as well as the need for effective communication between patients and providers.
Current treatment limitations in inflammatory bowel disease and the rationale for earlier initiation and use of newer therapies to manage pediatric and adult patients.
Jessica Allegretti, MD, MPH, and Edward Loftus Jr., MD, review emerging agents in the later phases for the management of IBD.
Retina specialists share advice and practice pearls regarding the management of DME and neovascular AMD, including counseling patients about the importance of healthy lifestyles.
Patients with rheumatoid arthritis are at a greater risk of dementia, but why? Take this quiz to test your knowledge of the association between rheumatoid arthritis and dementia.
Experts in pediatric hepatology share advice for the optimal management of Alagille syndrome.
Ana-Maria Orbai, MD, MHS, leads the discussion on a real-world case scenario of a 57-year-old man who presents with severe plaque psoriasis and arthritis and shares clinical impressions as well as therapeutic goals for the patient.
Experts in gastroenterology share advice for the treatment of patients of Crohn’s disease.
This article is the final installment of four articles exploring the epidemic of liver disease called nonalcoholic fatty liver disease and its more severe form, nonalcoholic steatohepatitis.
Experts in dermatology share advice on helping fellow physicians stay apprised of the advances in AD and treat their patients more effectively.
Drs Rakesh Jain, Greg Mattingly, David W. Goodman, Birgit H. Amann, and Theresa R. Cerulli, discuss emerging agents in the pipeline for the management of pediatric and adult ADHD.
Expert cardiologists share strategies for educating patients on the treatment and management of hypertrophic cardiomyopathy.
Expert clinicians discuss insulin therapy for treating type 2 diabetes and comment on what to look forward to in the future of diabetes care.
A panel of eye care specialists share clinical advice and future directions for the treatment of wet AMD.
Closing out their discussion, experts highlight practical advice for caring for patients with SARDs in the current treatment landscape.
Nehad Soloman, MD; Joy Schechtman, DO; and Robert Levin, MD, share final thoughts and takeaways on the treatment of rheumatoid arthritis in the community setting.
Iltefat Hamzavi, MD, explores key areas of patient communication that may shape adherence and outcomes in patients with vitiligo.
Alexa Hetzel, MA, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, and Matthew Brunner, PA, share practice pearls and clinical management tips for the care of pediatric patients with atopic dermatitis.
Lawrence F. Eichenfield, MD; Jeffrey M. Bienstock, MD, FAAP; Peter A. Lio, MD; and Elizabeth A. Swanson, MD, review additional mechanisms being investigated in the pipeline for the treatment of atopic dermatitis.
Closing their discussion on insomnia, panelists share final thoughts and advice for community physicians.
Wally Smith, MD, shares his take-home points for patients with sickle cell disease and urges to get tested for sickle cell trait.
Key opinion leaders emphasize important considerations when discussing the safety of anti-VEGF agents with patients and highlight unmet needs in nonproliferative diabetic retinopathy treatments.
Experts in dermatology stress the importance of patient education in atopic dermatitis management and discuss their approaches to keeping patients up-to date.
The systematic review summarized the impact of biologics targeting the IL-23/Th17 axis.
A longtime clinician writes on the signs and risks of fatal heart attack events, including the Widowmaker.
Closing out its discussion on atopic dermatitis, the panel considers best practices and unmet needs in the treatment landscape.
Concluding their discussion on sickle cell disease management, expert panelists share key unmet needs and hopes for the future.